Risk of hypersensitivity reaction in infants and children following administration of Nevirapine
This communication is to remind you about the risk of hypersensitivity reaction in infants and children receiving Nevirapine which may have fatal outcomes. The National Pharmacovigilance Centre has received cases of preventable death as a result of septicaemia which was secondary to Nevirapine hypersensitivity. When children develop rash due to Nevirapine hypersensitivity and the care…
